Within the pharmaceutical industry, a drug targeting ‘all-comers’ mean it is indicated to treat all patients in non-specific stages of disease.

A drug proving treatment efficacy regardless of receptor or genetic mutation sound interesting and appealing. However, the South Korean government is still conservative on the all-comers drug to this date.

In some ways, it seems obvious. A wide use of a drug means increase volume of the drug used, which could develop a whole financial issue. But there seems to be more than a financial issue why the government is taking a rather cautious stance, or the careful approach on the all-comers drug.

Some say the government is skeptica